Please login to the form below
Youssef Bennani to chair Domain Therapeutics
He is VP R&D at Vertex
Domain Therapeutics has named Youssef Bennani as chairman of the company's board, taking over from Sam Eletr.
Bennani currently serves as site head and VP of R&D at Vertex Pharmaceuticals' site in Laval, Quebec. Prior to this, he spent seven years as VP of drug innovation at Vertex .
“Dr Bennani joins us at a time when we intend to strengthen our role as a pharma industry partner and expand our internal pipeline,” said Pascal Neuville, board director and CEO of Domain.
This pipeline includes new drug candidates targeting G protein-coupled receptors. Domain has several partnerships involving these products, including one with Merck Serono in Parkinson's disease.
Featured jobs
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Medical Writer
-
Competitive Salary
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Account Director
-
Excellent benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Medical/ Scientific Director
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director
-
£48, 000 - £60, 000
-
Medical Writers
-
Competitive Salary and Benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- Oral Appliances lead Sleep Apnea Devices Market Growth, Shows Recent Analysis
- Animal Healthcare Market is poised to cross USD 36 billion by 2024
- Fishawack launches new website and introduces new structure for growth
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- Orphan drugs from Biogen and Amicus win UK Prix Galien
- AZ’s MYSTIC survival data is in – and it’s a bust
PMHub
OPEN Access Consulting
OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
